This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Strickler, H. D. Articles by Schiller, J. T. Search for Related Content PubMed PubMed Citation Articles by Strickler, H. D. Articles by Schiller, J. T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 07 1997, 1751-1756, Vol 35, No. 7
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays

HD Strickler, A Hildesheim, RP Viscidi, KV Shah, B Goebel, J Drummond, D Waters, Y Sun, NL Hubbert, S Wacholder, LA Brinton, CL Han, PC Nasca, R McClimens, K Turk, V Devairakkam, S Leitman, C Martin and JT Schiller
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Serological assays for measuring antibodies to human papillomavirus type 16 (HPV-16) virus-like particles (VLPs) have become important epidemiologic tools in recent years. However, the interlaboratory replicability of these assays has not been assessed. In this investigation, three laboratories tested a panel of specimens obtained from two different groups: 265 subjects in a vulvar cancer case-control study and 107 healthy volunteer blood donors. Each laboratory used an enzyme-linked immunosorbent assay (ELISA), but no attempt was made to standardize assay procedures among the three laboratories. The data showed good day-to-day intralaboratory replicability in laboratory 1 (correlation coefficient, > or = 0.88) and good intra-assay variability in laboratory 3 (correlation coefficient, > or = 0.93). Interlaboratory correlations, likewise, ranged between 0.61 and 0.80 in both case- control study subjects and healthy blood donors, indicating that ELISA optical density (OD) values between laboratories were linearly related regardless of the population. Kappa coefficients (kappa), based on each laboratory's categorical interpretation of its results (as positive or negative), showed good agreement (kappa, > 0.6) in case-control study subjects and moderate agreement (kappa, > or = 0.4) in blood donors, a population that had few strongly positive sera. When OD values near seropositive cutoffs were treated as indeterminates, there was little discordance between laboratories in either population. The data suggest that each laboratory measured the same humoral immune response and that their HPV-16 VLP ELISAs performed similarly (Pearson correlations). Interlaboratory differences, however, probably due to reagents and procedures, were considerably greater than intralaboratory day-to-day variability. Interlaboratory agreement in determining seropositivity (kappa) could be improved by sharing positive and negative serum controls and by treating marginal results as indeterminate. As part of continuing cooperation to improve interlaboratory agreement, we are preparing bulk serum control specimens to be shared and made available to interested researchers.

This article has been cited by other articles:

• Senger, T., Becker, M. R., Schadlich, L., Waterboer, T., Gissmann, L. (2009). Identification of B-Cell Epitopes on Virus-Like Particles of Cutaneous Alpha-Human Papillomaviruses. J. Virol. 83: 12692-12701 [Abstract] [Full Text]  
• Shields, T. S., Brinton, L. A., Burk, R. D., Wang, S. S., Weinstein, S. J., Ziegler, R. G., Studentsov, Y. Y., McAdams, M., Schiffman, M. (2004). A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus. Cancer Epidemiol. Biomarkers Prev. 13: 1574-1582 [Abstract] [Full Text]  
• Cameron, J. E., Snowhite, I. V., Chaturvedi, A. K., Hagensee, M. E. (2003). Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive Individuals. CVI 10: 431-438 [Abstract] [Full Text]  
• Lehtinen, M., Koskela, P., Jellum, E., Bloigu, A., Anttila, T., Hallmans, G., Luukkaala, T., Thoresen, S., Youngman, L., Dillner, J., Hakama, M. (2002). Herpes Simplex Virus and Risk of Cervical Cancer: A Longitudinal, Nested Case-Control Study in the Nordic Countries. Am J Epidemiol 156: 687-692 [Abstract] [Full Text]  
• Karem, K. L., Poon, A. C., Bierl, C., Nisenbaum, R., Unger, E. (2002). Optimization of a Human Papillomavirus-Specific Enzyme-Linked Immunosorbent Assay. CVI 9: 577-582 [Abstract] [Full Text]  
• Studentsov, Y. Y., Schiffman, M., Strickler, H. D., Ho, G. Y. F., Pang, Y.-Y. S., Schiller, J., Herrero, R., Burk, R. D. (2002). Enhanced Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Virus-Like Particles of Human Papillomavirus. J. Clin. Microbiol. 40: 1755-1760 [Abstract] [Full Text]  
• Weinstein, S. J., Ziegler, R. G., Frongillo, E. A. Jr., Colman, N., Sauberlich, H. E., Brinton, L. A., Hamman, R. F., Levine, R. S., Mallin, K., Stolley, P. D., Bisogni, C. A. (2001). Low Serum and Red Blood Cell Folate Are Moderately, but Nonsignificantly Associated with Increased Risk of Invasive Cervical Cancer in U.S. Women. J. Nutr. 131: 2040-2048 [Abstract] [Full Text]  
• Kibur, M, Geijerstamm, V A., Pukkala, E, Koskela, P, Luostarinen, T, Paavonen, J, Schiller, J, Wang, Z, Dillner, J, Lehtinen, M (2000). Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination. Sex. Transm. Infect. 76: 13-17 [Abstract] [Full Text]